Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 22, 2021
Bacterial and Viral Respiratory Tract Microbiota and Host Characteristics in Adults With Lower Respiratory Tract Infections: A Case-Control Study
Bastiaan W Haak, Xanthe Brands, Mark Davids, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 2, 2011
Follow-up of 686 patients with acute Q fever and detection of chronic infection
Wim van der Hoek, Bart Versteeg, Jamie C E Meekelenkamp, et al.
Cell Reports. Medicine
|
March 8, 2021
Low awareness of past SARS-CoV-2 infection in healthy plasma donors
Katja van den Hurk, Eva-Maria Merz, Femmeke J Prinsze, et al.
The Lancet. Gastroenterology & Hepatology
|
May 20, 2017
Peg-interferon plus nucleotide analogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial
Annikki de Niet, Louis Jansen, Femke Stelma, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
March 26, 2016
Seroprevalence of Hepatitis E Virus in Autoimmune Hepatitis Patients in the Netherlands
Nicole M F van Gerven, Annemiek A van der Eijk, Suzan D Pas, et al.
Antiviral Therapy
|
May 4, 2013
Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with pegylated interferon-α2a and adefovir
R Bart Takkenberg, Louis Jansen, Annikki de Niet, et al.
Emerging Infectious Diseases
|
December 21, 2006
Fourth human parechovirus serotype
Kimberley S M Benschop, Janke Schinkel, Manon E Luken, et al.
Gastroenterology
|
August 31, 2010
Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus
Theodora E M S de Vries-Sluijs, Jurriën G P Reijnders, Bettina E Hansen, et al.
Psychiatry Research
|
August 26, 2015
Viral metagenomics in drug-naïve, first-onset schizophrenia patients with prominent negative symptoms
Marta Canuti, Nico J M van Beveren, Seyed Mohammad Jazaeri Farsani, et al.
The Journal of Infectious Diseases
|
July 12, 2012
Hepatitis B surface antigen declines and clearance during long-term tenofovir therapy in patients coinfected with HBV and HIV
Roeland Zoutendijk, Hans L Zaaijer, Theodora E M S de Vries-Sluijs, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 22, 2021
Bacterial and Viral Respiratory Tract Microbiota and Host Characteristics in Adults With Lower Respiratory Tract Infections: A Case-Control Study
Bastiaan W Haak, Xanthe Brands, Mark Davids, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 2, 2011
Follow-up of 686 patients with acute Q fever and detection of chronic infection
Wim van der Hoek, Bart Versteeg, Jamie C E Meekelenkamp, et al.
Cell Reports. Medicine
|
March 8, 2021
Low awareness of past SARS-CoV-2 infection in healthy plasma donors
Katja van den Hurk, Eva-Maria Merz, Femmeke J Prinsze, et al.
The Lancet. Gastroenterology & Hepatology
|
May 20, 2017
Peg-interferon plus nucleotide analogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial
Annikki de Niet, Louis Jansen, Femke Stelma, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD
|
March 26, 2016
Seroprevalence of Hepatitis E Virus in Autoimmune Hepatitis Patients in the Netherlands
Nicole M F van Gerven, Annemiek A van der Eijk, Suzan D Pas, et al.
Antiviral Therapy
|
May 4, 2013
Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with pegylated interferon-α2a and adefovir
R Bart Takkenberg, Louis Jansen, Annikki de Niet, et al.
Emerging Infectious Diseases
|
December 21, 2006
Fourth human parechovirus serotype
Kimberley S M Benschop, Janke Schinkel, Manon E Luken, et al.
Gastroenterology
|
August 31, 2010
Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus
Theodora E M S de Vries-Sluijs, Jurriën G P Reijnders, Bettina E Hansen, et al.
Psychiatry Research
|
August 26, 2015
Viral metagenomics in drug-naïve, first-onset schizophrenia patients with prominent negative symptoms
Marta Canuti, Nico J M van Beveren, Seyed Mohammad Jazaeri Farsani, et al.
The Journal of Infectious Diseases
|
July 12, 2012
Hepatitis B surface antigen declines and clearance during long-term tenofovir therapy in patients coinfected with HBV and HIV
Roeland Zoutendijk, Hans L Zaaijer, Theodora E M S de Vries-Sluijs, et al.
Page
of 10